Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes.

Yenamandra SP, Hellman U, Kempkes B, Darekar SD, Petermann S, Sculley T, Klein G, Kashuba E.

Cell Mol Life Sci. 2010 Dec;67(24):4249-56. doi: 10.1007/s00018-010-0441-4. Epub 2010 Jul 1.

PMID:
20593215
2.

Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling.

Schroder WA, Buck M, Cloonan N, Hancock JF, Suhrbier A, Sculley T, Bushell G.

Cell Signal. 2007 Jun;19(6):1279-89. Epub 2007 Jan 20.

PMID:
17303383
3.

Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.

Lovelock PK, Wong EM, Sprung CN, Marsh A, Hobson K, French JD, Southey M, Sculley T, Pandeya N, Brown MA, Chenevix-Trench G, Spurdle AB, McKay MJ; kConFab Investigators.

Breast Cancer Res Treat. 2007 Sep;104(3):257-66. Epub 2006 Oct 25.

PMID:
17063265
4.

Epstein-Barr virus nuclear antigen 3A contains six nuclear-localization signals.

Buck M, Burgess A, Stirzaker R, Krauer K, Sculley T.

J Gen Virol. 2006 Oct;87(Pt 10):2879-84.

PMID:
16963745
5.

mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s.

Frias MA, Thoreen CC, Jaffe JD, Schroder W, Sculley T, Carr SA, Sabatini DM.

Curr Biol. 2006 Sep 19;16(18):1865-70. Epub 2006 Aug 17.

6.

Nuclear localization of the Epstein-Barr virus EBNA3B protein.

Burgess A, Buck M, Krauer K, Sculley T.

J Gen Virol. 2006 Apr;87(Pt 4):789-93.

PMID:
16528026
7.

The human stress-activated protein kinase-interacting 1 gene encodes JNK-binding proteins.

Schroder W, Bushell G, Sculley T.

Cell Signal. 2005 Jun;17(6):761-7. Epub 2004 Dec 15.

PMID:
15722200
8.

Alternative polyadenylation and splicing of mRNAs transcribed from the human Sin1 gene.

Schroder W, Cloonan N, Bushell G, Sculley T.

Gene. 2004 Sep 15;339:17-23.

PMID:
15363842
9.

The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.

Krauer KG, Buck M, Belzer DK, Flanagan J, Chojnowski GM, Sculley TB.

Virology. 2004 Jan 5;318(1):280-94.

10.

Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.

Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.

Arch Virol. 2004 Feb;149(2):289-302. Epub 2003 Nov 4.

PMID:
14745596
11.

Identification of the nuclear localization signals within the Epstein-Barr virus EBNA-6 protein.

Krauer K, Buck M, Flanagan J, Belzer D, Sculley T.

J Gen Virol. 2004 Jan;85(Pt 1):165-72.

PMID:
14718631
12.

The EBNA-3 gene family proteins disrupt the G2/M checkpoint.

Krauer KG, Burgess A, Buck M, Flanagan J, Sculley TB, Gabrielli B.

Oncogene. 2004 Feb 19;23(7):1342-53.

PMID:
14716295
13.

Localization of the Epstein-Barr virus protein LMP 1 to exosomes.

Flanagan J, Middeldorp J, Sculley T.

J Gen Virol. 2003 Jul;84(Pt 7):1871-9.

PMID:
12810882
14.

Antiserum raised against the Epstein-Barr virus BARF0 protein reacts to HLA-DR beta chain.

Schroder W, Kienzle N, Bushell G, Sculley T.

Arch Virol. 2002 Apr;147(4):723-9.

PMID:
12038683
16.

Characterization of the transcriptional repressor RBP in Epstein-Barr virus-transformed B cells.

Krauer KG, Buck M, Sculley T.

J Gen Virol. 1999 Dec;80 ( Pt 12):3217-26.

PMID:
10567654
17.

Epstein-Barr virus-encoded RK-BARF0 protein expression.

Kienzle N, Buck M, Greco S, Krauer K, Sculley TB.

J Virol. 1999 Oct;73(10):8902-6.

19.

A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle.

Buck M, Cross S, Krauer K, Kienzle N, Sculley TB.

J Gen Virol. 1999 Feb;80 ( Pt 2):441-5.

PMID:
10073706
20.

Intron retention may regulate expression of Epstein-Barr virus nuclear antigen 3 family genes.

Kienzle N, Young DB, Liaskou D, Buck M, Greco S, Sculley TB.

J Virol. 1999 Feb;73(2):1195-204.

21.

Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.

Krauer KG, Belzer DK, Liaskou D, Buck M, Cross S, Honjo T, Sculley T.

Virology. 1998 Dec 20;252(2):418-30.

22.

Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.

Kienzle N, Sculley TB, Poulsen L, Buck M, Cross S, Raab-Traub N, Khanna R.

J Virol. 1998 Aug;72(8):6614-20.

23.

Both A type and B type Epstein-Barr virus nuclear antigen 6 interact with RBP-2N.

Young DB, Krauer K, Kienzle N, Sculley T.

J Gen Virol. 1997 Jul;78 ( Pt 7):1671-4.

PMID:
9225044
24.

Evidence that the expression and phosphorylation status of pleckstrin is modulated by Epstein-Barr virus in human B lymphocytes.

Kienzle N, Cross S, Young DB, Misko I, Sculley TB, Abrams CS.

Blood. 1997 May 1;89(9):3488-90. No abstract available.

PMID:
9129059
25.

Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.

Fries KL, Sculley TB, Webster-Cyriaque J, Rajadurai P, Sadler RH, Raab-Traub N.

J Virol. 1997 Apr;71(4):2765-71.

26.

Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2N, a major isoform of RBP-J kappa in B lymphocytes.

Krauer KG, Kienzle N, Young DB, Sculley TB.

Virology. 1996 Dec 15;226(2):346-53.

27.

Identification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.

Kerr BM, Kienzle N, Burrows JM, Cross S, Silins SL, Buck M, Benson EM, Coupar B, Moss DJ, Sculley TB.

J Virol. 1996 Dec;70(12):8858-64.

28.

Induction of pleckstrin by the Epstein-Barr virus nuclear antigen 3 family.

Kienzle N, Young D, Silins SL, Sculley TB.

Virology. 1996 Oct 1;224(1):167-74.

29.
30.

DNaseI treatment is a prerequisite for the amplification of cDNA from episomal-based genes.

Kienzle N, Young D, Zehntner S, Bushell G, Sculley TB.

Biotechniques. 1996 Apr;20(4):612-6. No abstract available.

31.
32.

Managing HIV. Part 3: Mechanisms of disease. 3.6 How HIV promotes malignancies.

Boyle MJ, Goldstein DA, Frazer IH, Sculley TB.

Med J Aust. 1996 Feb 19;164(4):230-2. Review. No abstract available.

PMID:
8604195
33.
34.

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

Argaet VP, Schmidt CW, Burrows SR, Silins SL, Kurilla MG, Doolan DL, Suhrbier A, Moss DJ, Kieff E, Sculley TB, Misko IS.

J Exp Med. 1994 Dec 1;180(6):2335-40.

35.

Detection of A-type and B-type Epstein-Barr virus in throat washings and lymphocytes.

Apolloni A, Sculley TB.

Virology. 1994 Aug 1;202(2):978-81.

PMID:
8030259
37.

Epstein-Barr virus-specific cytotoxic T cell response in cardiac transplant recipients.

Kyaw-Tanner MT, Esmore D, Burrows SR, Benson EM, Sculley TB.

Transplantation. 1994 Jun 15;57(11):1611-7.

PMID:
8009596
38.

Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus.

Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB.

J Gen Virol. 1994 Jan;75 ( Pt 1):95-100.

PMID:
8113744
39.

EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.

Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rowe M, Rickinson AB, Moss DJ.

J Immunol. 1993 Jun 1;150(11):5154-62.

PMID:
7684421
40.

The role of Epstein-Barr virus subtypes in human immunodeficiency virus-associated lymphoma.

Boyle MJ, Sculley TB, Penny R, Sewell WA, Tschuchnigg M, Berger MF, Cooper DA.

Leuk Lymphoma. 1993 May;10(1-2):17-23. Review.

PMID:
8397031
41.

Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise.

Boyle MJ, Vasak E, Tschuchnigg M, Turner JJ, Sculley T, Penny R, Cooper DA, Tindall B, Sewell WA.

Blood. 1993 Jan 15;81(2):468-74.

PMID:
8380726
42.

Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients.

Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, Esmore D, Sculley TB.

AIDS Res Hum Retroviruses. 1992 Nov;8(11):1869-74.

PMID:
1336962
43.

Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.

Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ.

J Exp Med. 1992 Jul 1;176(1):169-76.

44.

Isolation of Epstein-Barr virus genomes using pulse-field gel electrophoresis.

Silins SL, Argaet VP, Sculley TB.

Nucleic Acids Res. 1992 Jun 11;20(11):2901. No abstract available.

45.

Immune surveillance against Epstein-Barr virus.

Moss DJ, Burrows SR, Khanna R, Misko IS, Sculley TB.

Semin Immunol. 1992 Apr;4(2):97-104. Review.

PMID:
1377517
46.

Epstein-Barr virus and HIV play no direct role in persistent generalized lymphadenopathy syndrome.

Boyle MJ, Sculley TB, Cooper DA, Turner JJ, Penny R, Sewell WA.

Clin Exp Immunol. 1992 Mar;87(3):357-61.

47.

Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.

Misko IS, Schmidt C, Honeyman M, Soszynski TD, Sculley TB, Burrows SR, Moss DJ, Burman K.

Clin Exp Immunol. 1992 Jan;87(1):65-70.

48.

Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus.

Apolloni A, Moss D, Stumm R, Burrows S, Suhrbier A, Misko I, Schmidt C, Sculley T.

Eur J Immunol. 1992 Jan;22(1):183-9.

PMID:
1370413
49.

Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma.

Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA.

Blood. 1991 Dec 1;78(11):3004-11.

PMID:
1659471
50.

Supplemental Content

Loading ...
Support Center